Women’s Health: Addressing Gender Inequities in Research & Pay | Healio

The observance of International Women’s Day on March 8th serves as a crucial reminder of ongoing inequities, including those deeply embedded within medical research. A growing awareness is highlighting how historically, the male body has often been used as the default template for understanding health and disease, leading to significant gaps in knowledge about how conditions affect women – and suboptimal care.

These gaps aren’t simply about a lack of representation in clinical trials; they extend to fundamental aspects of medical equipment design, medication dosing, and even the prioritization of research funding. As Louise P. King, MD, JD, a surgeon and assistant professor at Harvard Medical School, explains, the issue is pervasive. “I could suppose of a million areas where female representation in clinical trials falls short,” she said in a recent interview with Healio.

The Historical Exclusion of Women

For decades, women were routinely excluded from clinical trials for a variety of reasons. Concerns about hormonal fluctuations complicating study results, and fears about potential harm to a developing fetus (teratogenicity) were often cited. While these concerns weren’t entirely unfounded, they resulted in a systematic underrepresentation that has left significant blind spots in our understanding of women’s health. This exclusion wasn’t simply a matter of convenience; it was often actively justified by a belief that women’s bodies were too “complex” to study effectively.

This historical bias has had tangible consequences. For example, women experience heart attacks differently than men, often presenting with less typical symptoms. Given that early research focused primarily on male patients, these differences weren’t fully recognized, leading to delayed diagnoses and poorer outcomes for women. Research increasingly demonstrates links between conditions predominantly affecting women, like uterine fibroids, and cardiovascular disease, further emphasizing the need for inclusive research.

Areas Demanding Greater Focus

While progress is being made, Dr. King emphasizes that much more work remains. She points to several areas where increased female representation in clinical trials is particularly critical, including cardiovascular health, rheumatologic diseases (like multiple sclerosis), and endometriosis. Recent updates to guidance on diagnosing endometriosis from the American College of Obstetricians and Gynecologists underscore the importance of focused research into this often debilitating condition.

Beyond these specific areas, Dr. King also highlights the need for more research into conditions unique to women, such as those related to pregnancy and menopause. She also stresses the importance of addressing the unique health challenges faced by pregnant women, noting that they were often excluded from trials due to safety concerns.

Beyond Representation: Addressing Systemic Inequities

The issue extends beyond simply including more women in clinical trials. Systemic inequities in funding and reimbursement also play a significant role. Dr. King points out that healthcare services specific to women are often reimbursed at a lower rate than those for men, creating a financial disincentive for research and care in these areas.

women in medicine often face a significant pay gap. Studies have shown that female oncologists, for example, receive significantly lower payments from industry than their male counterparts. This disparity not only affects individual physicians but also limits the pipeline of female leaders in medical research and practice.

Innovations in Obstetrics and Gynecology

Despite these challenges, there are promising developments in obstetrics and gynecology. Research into abnormal placentation (placenta accreta/increta) is yielding new insights into this potentially life-threatening condition. Efforts to prevent premature births, eclampsia, and preeclampsia are also showing positive results. Recent research suggests that prescribing daily aspirin to all pregnant patients may reduce the risk of preeclampsia, a significant advancement in preventative care.

In gynecologic surgery, advancements are being made in optimizing surgical approaches and expanding access to minimally invasive procedures. However, even in these areas, Dr. King notes that equipment is often designed with the male anatomy in mind, potentially leading to discomfort and even injury for female surgeons.

The Need for Equitable Pay and Reimbursement

If she could address one issue related to women’s health, Dr. King says it would be achieving equal pay and equal reimbursement. “I would level the playing field, both for patients and doctors,” she states. She argues that increased funding for women’s health research, standard care, and salaries would have a transformative impact, addressing many of the existing inequities.

Looking Ahead: A Call to Action

As International Women’s Day approaches, Dr. King’s message to physicians is one of encouragement and perseverance. She acknowledges the burnout prevalent in medicine, particularly in fields related to women’s health, but urges colleagues to remain committed to the fight for equity. “Maintain up the quality fight. Keep yourself in that space. Don’t leave. We’re going to make things better. We’re going to make progress, and we need you.”

The path toward gender equity in medical research is a long one, but it is a necessary one. By acknowledging the historical biases, addressing systemic inequities, and prioritizing research that reflects the diversity of the population, we can ensure that all patients receive the best possible care.

For more information: [email protected].

As reported by the Federal Trade Commission on February 4, 2026, National Consumer Protection Week (NCPW) is underway, running from March 1-7, 2026. The FTC is amplifying the importance of consumer protection during this period, a reminder to remain vigilant against scams and fraud. Individuals awaiting tax refunds should be aware of potential discrepancies, as noted in a Facebook post from March 4, 2026, advising to check with their bank by March 9, 2026, if a refund isn’t received. More information can be found on Facebook. Finally, the Supreme Court of Georgia issued an email scam alert on January 22, 2026, warning of fraudulent emails and advising individuals to contact the Court directly to verify any suspicious communications. Details about the scam alert are available on the Supreme Court of Georgia website.